STOCK TITAN

Runway Growth Capital Promotes Avisha Khubani to Chief Credit Officer and Adds JD Tamas as Managing Director

(Neutral)
(Neutral)
Tags

Runway Growth Capital (RWAY) promoted Avisha Khubani to Chief Credit Officer and hired John D. "JD" Tamas as Managing Director for healthcare and life sciences, effective May 6, 2026. Khubani will oversee portfolio monitoring, valuation, and risk management; Tamas joins following Runway Growth Finance Corp.'s acquisition of SWK Holdings to expand sector capabilities.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – RWAY

+0.29%
+0.29% Session close to close

In the May 7 session, RWAY gained 0.29%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights continuity and specialization in RWAY’s credit leadership as it integra...
Analysis

This announcement highlights continuity and specialization in RWAY’s credit leadership as it integrates the SWK platform. Elevating a long-tenured portfolio analytics executive to Chief Credit Officer and adding a healthcare-focused managing director dovetails with the recent move to expand healthcare and life sciences exposure to about 32% and pro forma assets to $1.2 billion. In context of prior earnings, dividends, and the SWK acquisition, investors may watch how these leaders influence underwriting discipline and portfolio risk management over time.

Key Figures

Leadership tenure: eight years Join date: October 2018 Announcement date: May 6, 2026
3 metrics
Leadership tenure eight years Time Avisha Khubani has contributed to portfolio analytics and credit capabilities
Join date October 2018 Month and year Avisha Khubani joined Runway
Announcement date May 6, 2026 Date of leadership promotion and appointment press release

Historical Context

5 past events · Latest: Apr 15 (Neutral)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Apr 15 Earnings call date Neutral +4.8% Set Q1 2026 results release and conference call timing for investors.
Apr 07 Acquisition close Positive -2.8% Closed SWK Holdings acquisition, expanding assets and healthcare exposure.
Mar 12 Earnings results Positive -7.4% Reported FY 2025 results, strong income metrics, and declared dividend.
Feb 26 Dividend declaration Positive +1.0% Announced Q1 2026 cash dividend of $0.33 per share.
Feb 10 Earnings call date Neutral +1.5% Scheduled Q4 and FY 2025 results release and conference call.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent history shows mixed reactions: the SWK acquisition and strong FY 2025 metrics drew negative moves, while dividends and earnings-date announcements tended to see modest gains.

Recent Company History

Over the last few months, RWAY has focused on growth and capital structure. It closed the SWK Holdings acquisition on Apr 6, 2026, lifting pro forma assets to $1.2 billion and healthcare/life sciences exposure to about 32%. FY 2025 results highlighted a $927.4M portfolio and $137.3M total investment income, alongside a $0.33 quarterly dividend. Earnings call dates on Feb 10 and Apr 15 and a Q1 2026 dividend announcement on Feb 26 also framed expectations. Today’s leadership moves build on this expanded credit platform and sector focus.

Key Terms

private credit, structured finance
2 terms
private credit financial
"has held investment roles across the private credit and structured finance markets"
Private credit is a form of borrowing where companies or organizations obtain loans directly from private lenders rather than traditional banks or financial markets. It often involves customized financing arrangements that are not traded publicly, making it a way for businesses to access funding outside of standard channels. For investors, private credit offers the potential for higher returns, but typically comes with increased risk and less liquidity compared to more conventional investments.
structured finance financial
"has held investment roles across the private credit and structured finance markets"
Structured finance is a way of turning a group of financial assets — like loans, mortgages, or receivables — into new investment products by pooling them together and slicing that pool into pieces with different levels of risk and return. For investors, it matters because these products can offer higher yields or tailored risk exposure than plain stocks or bonds, but they can also hide complexity and sensitivity to the underlying assets’ performance, so understanding what you own is key.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Personnel moves expand the firm's credit leadership and strengthen its healthcare and life sciences investing capabilities

MENLO PARK, Calif., May 6, 2026 /PRNewswire/ -- Runway Growth Capital LLC ("Runway"), a leading provider of growth loans to venture and non-venture–backed companies, today announced the promotion of Avisha Khubani, CFA, to Chief Credit Officer and the appointment of John D. ("JD") Tamas as Managing Director, focused on the healthcare and life sciences industries.

In her new role, Khubani will help oversee Runway's credit function, including portfolio monitoring, valuation, and ongoing risk management, while working with the investment team to support the firm's disciplined credit strategy. Tamas joins Runway's investment team following Runway Growth Finance Corp.'s recent acquisition of SWK Holdings, helping to expand the firm's capabilities and relationships across the healthcare and life sciences sectors.

"Avisha has played a critical role in building and scaling our portfolio analytics and credit capabilities over the past eight years, and her promotion reflects her exceptional judgment, analytical rigor, and leadership," said David Spreng, Founder, CEO, and Chief Investment Officer of Runway Growth Capital. "We're also excited to welcome JD, whose experience underwriting and investing across healthcare and life sciences strengthens our investment capabilities."

Khubani, who most recently served as Managing Director, Portfolio Analytics, joined Runway in October 2018 and has held roles of increasing responsibility across portfolio valuation, analytics, and portfolio monitoring and management. Before joining Runway, she was a Vice President at Duff & Phelps in the Portfolio Valuation service line, where she performed valuations of portfolios of illiquid equity interests held by large private equity funds and valued complex portfolios of private loans and equity.

"I'm excited to step into this role and continue working with such a thoughtful and talented team," explained Khubani. "Runway has always taken a disciplined, partnership-oriented approach, and I look forward to building on that as we support our portfolio companies and investors."

Tamas joins Runway as Managing Director, focused on the healthcare and life sciences industries. He previously served as Director of Underwriting at SWK Holdings and has held investment roles across the private credit and structured finance markets, including at NXT Capital and Orix Corporation.

"I'm eager to join Runway and contribute to its continued growth with my experience structuring healthcare-focused credit investments," added Tamas. "I look forward to helping expand the firm's network and capabilities across healthcare and life sciences."

Khubani received her M.B.A. from New York University Stern School of Business and her undergraduate degree from Montclair State University. Tamas holds an M.B.A. from The Wharton School and an undergraduate degree from the University of Arkansas.

About Runway Growth Capital LLC
Runway Growth Capital LLC is the investment adviser to investment funds, including Runway Growth Finance Corp. (Nasdaq: RWAY), a business development company, and other private funds, which are lenders of growth capital to companies seeking an alternative to raising equity. Led by industry veteran David Spreng, these funds provide senior term loans of a target of $10 million to $150 million to fast-growing companies based in the United States and Canada. For more information on Runway Growth Capital LLC and its platform, please visit www.runwaygrowth.com.

Forward-Looking Statements
Statements included herein may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance, condition, or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in filings with the Securities and Exchange Commission made by Runway and Runway's affiliated funds. Neither Runway nor Runway's affiliated funds undertake a duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/runway-growth-capital-promotes-avisha-khubani-to-chief-credit-officer-and-adds-jd-tamas-as-managing-director-302764439.html

SOURCE Runway Growth Capital LLC

FAQ

Who is Avisha Khubani and what is her role at Runway Growth Capital (RWAY)?

Avisha Khubani is the newly promoted Chief Credit Officer at Runway Growth Capital. According to the company, she joined in October 2018, led portfolio analytics, and will now oversee portfolio monitoring, valuation, and ongoing credit risk management.

What will JD Tamas do as Managing Director at Runway Growth Capital (RWAY)?

JD Tamas will serve as Managing Director focused on healthcare and life sciences. According to the company, he brings underwriting and investment experience from SWK Holdings, NXT Capital, and Orix to expand sector-focused credit investing.

How does the appointment of JD Tamas relate to Runway Growth Finance Corp.'s corporate activity?

The hire follows Runway Growth Finance Corp.'s acquisition of SWK Holdings. According to the company, that acquisition helped expand Runway's relationships and capabilities across healthcare and life sciences sectors.

What responsibilities will Khubani have as Chief Credit Officer at Runway Growth Capital (RWAY)?

Khubani will oversee the firm's credit function, including portfolio monitoring, valuation, and ongoing risk management. According to the company, she will also work with the investment team on maintaining a disciplined credit strategy.

What experience do Khubani and Tamas bring to Runway Growth Capital (RWAY)?

Khubani brings portfolio valuation and analytics experience, including a prior role at Duff & Phelps. According to the company, Tamas brings underwriting and private credit experience from SWK Holdings, NXT Capital, and Orix.

Will these personnel changes at Runway Growth Capital (RWAY) affect the firm's investment focus?

The appointments aim to strengthen credit leadership and healthcare investing capabilities. According to the company, Khubani will enhance credit oversight while Tamas will expand healthcare and life sciences origination and structuring.